logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Improving The Quality Of Cancer Clinical Trials Workshop Summary 1st Edition Margie Patlak

  • SKU: BELL-1626788
Improving The Quality Of Cancer Clinical Trials Workshop Summary 1st Edition Margie Patlak
$ 31.00 $ 45.00 (-31%)

4.1

100 reviews

Improving The Quality Of Cancer Clinical Trials Workshop Summary 1st Edition Margie Patlak instant download after payment.

Publisher: National Academies Press
File Extension: PDF
File size: 4.17 MB
Pages: 136
Author: Margie Patlak, Sharyl Nass
ISBN: 9780309116688, 9780309116695, 0309116686, 0309116694
Language: English
Year: 2008
Edition: 1

Product desciption

Improving The Quality Of Cancer Clinical Trials Workshop Summary 1st Edition Margie Patlak by Margie Patlak, Sharyl Nass 9780309116688, 9780309116695, 0309116686, 0309116694 instant download after payment.

Scientists and clinicians seek a new paradigm that could improve the efficiency, cost-effectiveness, and overall success rate of cancer clinical trials, while maintaining the highest standards of quality. To explore innovative paradigms for cancer clinical trials and other ways to improve their quality, the National Cancer Policy Forum held a workshop, Improving the Quality of Cancer Clinical Trials, in Washington, DC. The main goals of the workshop were to examine new approaches to clinical trial design and execution that would: better inform decisions and plans of those responsible for developing new cancer therapies; more rapidly move new diagnostic tests and treatments toward regulatory approval and use in the clinic; and, be less costly than current trials. The resulting workshop summary will serve as input to the deliberations of an Institute of Medicine committee that will develop consensus-based recommendations for moving the field of cancer clinical trials forward.

Related Products